Immundiagnostik, Inc. Transitions to Eco-Friendly Kit Packaging to Further Support Sustainable Laboratory Initiatives

Manchester, NH, April 21, 2021 --(PR.com)-- Immundiagnostik, Inc., a North American immunoassay supplier, has transitioned its ELISA and assay kit packaging to eco-friendly materials made by Paper Foam® to further support sustainable laboratory initiatives. In addition to this new bio-based packaging, the organization offers custom bulk packaging services for high throughput research and clinical labs working to reduce their environmental impact.

“Many of our customers have been requesting more sustainable ELISA and assay kit packaging since we opened in 2018,” explains Immundiagnostik, Inc.’s Chief Operations Officer, Terry Fisher. “Our partners at Immundiagnostik AG in Germany selected the high-quality, durable bio-based materials from Paper Foam® to meet this need without sacrificing kit performance.”

In addition, Immundiagnostik has developed a customized bulk packaging service to assist high throughput labs in not only meeting the demands of testing, but also minimizing unnecessary waste. The company tailors its bulk packaging services to meet the needs and initiatives of each lab by consolidating assay kit and shipping materials to help reduce unnecessary waste.

“Research and clinical organizations have established initiatives to reduce their environmental impact and maximize lab and storage space, all while saving as much money as possible,” says Jen Mayes, Chief Sales Officer at Immundiagnostik. “We know the process of reaching these beneficial goals can be very challenging though, which is why we developed our customized bulk packaging service as an easy way for labs to take that first step.”

Visit idkna.com to learn more about Immundiagnostik, Inc.’s new eco-friendly kit packaging and customized bulk packaging services.

About Immundiagnostik, Inc.
Immundiagnostik, Inc. (IDK) is the North American subsidiary of Immundiagnostik AG based in Bensheim, Germany. We develop and manufacture innovative immunoassays and diagnostic detection methods for clinical and research laboratories. Our extensive product offering is continuously refueled by a rich pipeline of exclusive developments supported by collaborations with leading clinical and research laboratories, biopharma companies and a global network of key scientific pioneers.

Immundiagnostik, Inc. works to discover solutions on the cutting edge of science and develop reliable diagnostic tools for research and clinical laboratories to apply toward improving patient care.